CMS ends COVID blanket waivers for resident transfers and discharges, roommate changes … Imbalance in gum bacteria linked to Alzheimer’s biomarker … Risk of blood clots high following COVID hospitalization; anticoagulants cut risk 46% … More women than men getting COVID shots … CDC: Proportion of patients hospitalized with COVID heavily Latino, Hispanic … Diabetes drug Farxiga fails in coronavirus treatment trial
People with both visual and hearing impairments are twice as likely to develop dementia as their peers with only one impairment or normal sensory function, investigators say.
Effective, non-drug interventions can be prescribed by clinicians as part of an evidence-based treatment plan for depression in people with dementia, a geriatrician-researcher says.
In a love story that rivals “The Notebook,” a Michigan man has proven that no obstacle is too big to stop him from seeing his wife daily in a push to help her remember their love for one another.
Properly addressing the distress that underlies dementia-related behaviors is key to improving quality of life and preventing rapid decline in these patients, according to new guidance from leading dementia care providers.
A new blood test that detects the presence of Alzheimer’s brain plaques on Thursday became the first to hit the commercial market on a wide scale.
Advisers will consider whether to recommend that the amyloid beta-removing drug aducanumab be approved. The FDA has not reviewed an application for a new Alzheimer’s treatment for at least 15 years.
A large new study finds that people with type 2 diabetes have a 36% higher risk for vascular dementia when compared with people who do not have diabetes.
Highly rated operations had 3% fewer newly admitted residents with Alzheimer’s. CNA wages and Medicaid add-ons may play a role in the findings, report investigators.
People who eat a handful of grapes twice a day might cut their Alzheimer’s disease risk virtually in half, a new study suggests.
